These findings may help to explain the seemingly contradictory results obtained in different studies, such as a beneficial impact of a CXCR4 blockade in autoimmune diseases and a deleterious influence in ischemia and acute inflammation [14, 39]. This evidence concerns the gene CXCR4 and autoimmune disease.